Faculty Opinions recommendation of Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.

Publisher Website
Google Scholar
Abstract
This study showed a rapid improvement in vision and reduction in central foveal thickness (CFT) as compared to a sham group which may prove useful in the treatment of branch retinal vein occlusion (BRVO) and visually significant macular edema. RVO is a common retinal vasculopathy that frequently reduces vision secondary to macular edema. BRVOs account for a majority of RVOs. The vitreoretinal community has been largely successful...

This publication has 0 references indexed in Scilit: